Trial · NCT05552508
Outcomes37
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 20 of 37
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Change From Baseline in Untrimmed Total Mucus Volume at TLC | Baseline and Week 13 | Primary analysis population set consisted portion of the evaluable population that did not have any acute asthma exacerbation nor lower respiratory tract infection during the study period. | Milliliters (mL) | MEAN |
| SECONDARY | Change From Baseline in Untrimmed Total Mucus Plugs Score at TLC | Baseline and Week 13 | Primary analysis population set consisted portion of the evaluable population that did not have any acute asthma exacerbation nor lower respiratory tract infection during the study period. | Scores on a scale | MEAN |
| SECONDARY | Change From Baseline in Untrimmed Total Air Trapping at FRC | Baseline and Week 13 | Primary analysis population set consisted portion of the evaluable population that did not have any acute asthma exacerbation nor lower respiratory tract infection during the study period. Here, 'number of participants analyzed' specifies all participants who were evaluated for this outcome measure. | Percentage of air trapping | MEAN |
| SECONDARY | Change From Baseline in Trimmed Distal Airway Wall Volume at TLC | Baseline and Week 13 | Primary analysis population set consisted portion of the evaluable population that did not have any acute asthma exacerbation nor lower respiratory tract infection during the study period. | mL | MEAN |
| SECONDARY | Change From Baseline in Untrimmed Distal Airway Volume at TLC | Baseline and Week 13 | Primary analysis population set consisted portion of the evaluable population that did not have any acute asthma exacerbation nor lower respiratory tract infection during the study period. | mL | MEAN |
| SECONDARY | Change From Baseline in Untrimmed Distal Airway Volume at Functional Residual Capacity (FRC) | Baseline and Week 13 | Primary analysis population set consisted portion of the evaluable population that did not have any acute asthma exacerbation nor lower respiratory tract infection during the study period. Here, 'number of participants analyzed' specifies all participants who were evaluated for this outcome measure. | mL | MEAN |
| SECONDARY | Change From Baseline in Untrimmed Total Lung Volume at TLC | Baseline and Week 13 | Primary analysis population set consisted portion of the evaluable population that did not have any acute asthma exacerbation nor lower respiratory tract infection during the study period. | Liters (L) | MEAN |
| SECONDARY | Change From Baseline in Untrimmed Total Lung Volume at FRC | Baseline and Week 13 | Primary analysis population set consisted portion of the evaluable population that did not have any acute asthma exacerbation nor lower respiratory tract infection during the study period. Here, 'number of participants analyzed' specifies all participants who were evaluated for this outcome measure. | Liters (L) | MEAN |
| SECONDARY | Correlation Between Untrimmed Total Mucus Volume Measured at TLC and Pre-bronchodilator Forced Expiratory Volume in 1 Second (Pre-BD FEV1) | At Baseline (Week 0) | Baseline endpoints analysis set included all participants who had baseline measurements and who had at least one dose of study intervention. | Correlation coefficient | NUMBER |
| SECONDARY | Correlation Between Untrimmed Total Mucus Plugs Score at TLC and Pre-BD FEV1 | At Baseline (Week 0) | Baseline endpoints analysis set included all participants who had baseline measurements and who had at least one dose of study intervention. | Correlation coefficient | NUMBER |
| SECONDARY | Correlation Between Untrimmed Total Air Trapping at FRC and Pre-BD FEV1 | At Baseline (Week 0) | Baseline endpoints analysis set included all participants who had baseline measurements and who had at least one dose of study intervention. Here, 'number of participants analyzed' specifies all participants who were evaluated for this outcome measure. | Correlation coefficient | NUMBER |
| SECONDARY | Correlation Between Trimmed Distal Airway Wall Volume at TLC and Pre-BD FEV1 | At Baseline (Week 0) | Baseline endpoints analysis set included all participants who had baseline measurements and who had at least one dose of study intervention. Here, 'number of participants analyzed' specifies all participants who were evaluated for this outcome measure. | Correlation coefficient | NUMBER |
| SECONDARY | Correlation Between Untrimmed Distal Airway Volume at TLC and Pre-BD FEV1 | At Baseline (Week 0) | Baseline endpoints analysis set included all participants who had baseline measurements and who had at least one dose of study intervention. Here, 'number analyzed in each row' signifies the participants with available data that were analyzed for specified category. | Correlation coefficient | NUMBER |
| SECONDARY | Correlation Between Untrimmed Distal Airway Volume at FRC and Pre-BD FEV1 | At Baseline (Week 0) | Baseline endpoints analysis set included all participants who had baseline measurements and who had at least one dose of study intervention. Here, 'number analyzed in each row' signifies the participants with available data that were analyzed for specified category. | Correlation coefficient | NUMBER |
| SECONDARY | Correlation Between Untrimmed Total Lung Volume at TLC and Pre-BD FEV1 | At Baseline (Week 0) | Baseline endpoints analysis set included all participants who had baseline measurements and who had at least one dose of study intervention. Here, 'number analyzed in each row' signifies the participants with available data that were analyzed for specified category. | Correlation coefficient | NUMBER |
| SECONDARY | Correlation Between Untrimmed Total Lung Volume at FRC and Pre-BD FEV1 | At Baseline (Week 0) | Baseline endpoints analysis set included all participants who had baseline measurements and who had at least one dose of study intervention. Here, 'number analyzed in each row' signifies the participants with available data that were analyzed for specified category. | Correlation coefficient | NUMBER |
| SECONDARY | Correlation Between Untrimmed Total Mucus Volume Measured at TLC and Pre-bronchodilator Forced Vital Capacity (Pre-BD FVC) | At Baseline (Week 0) | Baseline endpoints analysis set included all participants who had baseline measurements and who had at least one dose of study intervention. | Correlation coefficient | NUMBER |
| SECONDARY | Correlation Between Untrimmed Total Mucus Plugs Score at TLC and Pre-BD FVC | At Baseline (Week 0) | Baseline endpoints analysis set included all participants who had baseline measurements and who had at least one dose of study intervention. | Correlation coefficient | NUMBER |
| SECONDARY | Correlation Between Untrimmed Total Air Trapping at FRC and Pre-BD FVC | At Baseline (Week 0) | Baseline endpoints analysis set included all participants who had baseline measurements and who had at least one dose of study intervention. Here, 'number of participants analyzed' specifies all participants who were evaluated for this outcome measure. | Correlation coefficient | NUMBER |
| SECONDARY | Correlation Between Trimmed Distal Airway Wall Volume at TLC and Pre-BD FVC | At Baseline (Week 0) | Baseline endpoints analysis set included all participants who had baseline measurements and who had at least one dose of study intervention. Here, 'number of participants analyzed' specifies all participants who were evaluated for this outcome measure. | Correlation coefficient | NUMBER |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05552508/outcomes